110 related articles for article (PubMed ID: 15536950)
1. [Usefulness of bone-specific alkaline phosphatase for bone metastases detection in prostate cancer].
Rasch-Isla Muñoz A; Cataño Cataño JG
Arch Esp Urol; 2004 Sep; 57(7):693-8. PubMed ID: 15536950
[TBL] [Abstract][Full Text] [Related]
2. Predictors of bone metastasis in pre-treatment staging of asymptomatic treatment-naïve patients with prostate cancer.
Moslehi M; Cheki M; Salehi-Marzijarani M; Amuchastegui T; Gholamrezanezhad A
Rev Esp Med Nucl Imagen Mol; 2013; 32(5):286-9. PubMed ID: 23478119
[TBL] [Abstract][Full Text] [Related]
3. Prediction of bone metastases by combination of tartrate-resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancer.
Ozu C; Nakashima J; Horiguchi Y; Oya M; Ohigashi T; Murai M
Int J Urol; 2008 May; 15(5):419-22. PubMed ID: 18452459
[TBL] [Abstract][Full Text] [Related]
4. [Relationship of serum prostate-specific antigen and alkaline phosphatase levels with bone metastases in patients with prostate cancer].
Wang ZL; Wang XF
Zhonghua Nan Ke Xue; 2005 Nov; 11(11):825-7. PubMed ID: 16333960
[TBL] [Abstract][Full Text] [Related]
5. Influence of local tumour stage and grade on reliability of serum prostate-specific antigen in predicting skeletal metastases in patients with adenocarcinoma of the prostate.
Bruwer G; Heyns CF; Allen FJ
Eur Urol; 1999; 35(3):223-7. PubMed ID: 10072624
[TBL] [Abstract][Full Text] [Related]
6. Prostate carcinoma staging. Clinical utility of bone alkaline phosphatase in addition to prostate specific antigen.
Morote J; Lorente JA; Encabo G
Cancer; 1996 Dec; 78(11):2374-8. PubMed ID: 8941009
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis of osseous metastases of malignant tumors by bone scanning combined with bone alkaline phosphatase detection].
Fan YX; Luo RC; Li GP; Huang K
Di Yi Jun Yi Da Xue Xue Bao; 2004 Jul; 24(7):812-4. PubMed ID: 15257911
[TBL] [Abstract][Full Text] [Related]
8. [Is skeletal alkaline phosphatase a valid staging marker in detection of osteoblastic skeletal metastases of prostate carcinoma?].
Wirtz DC; Wolff JM; Ittel TH; Jakse G; Niethard FU
Z Orthop Ihre Grenzgeb; 1998; 136(3):255-9. PubMed ID: 9736988
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer in patients from rural and suburban areas--PSA value, Gleason score and presence of metastases in bone scan.
Szot W; Kostkiewicz M; Zając J; Owoc A; Bojar I
Ann Agric Environ Med; 2014; 21(4):888-92. PubMed ID: 25528940
[TBL] [Abstract][Full Text] [Related]
10. Correlation of serum prostate specific antigen levels and bone scintigraphy in carcinoma prostate.
Oommen R; Geethanjali FS; Gopalakrishnan G; Chacko N; John S; Kanagasabapathy AS; Roul RK
Br J Radiol; 1994 May; 67(797):469-71. PubMed ID: 7514940
[TBL] [Abstract][Full Text] [Related]
11. [The indication of bone scan for patients with newly diagnosed prostate cancer].
Liu D; Wang W; Qiao LD; Zheng YP; Liu YX; Zhang GY; Chen S
Zhonghua Wai Ke Za Zhi; 2012 May; 50(5):443-5. PubMed ID: 22883953
[TBL] [Abstract][Full Text] [Related]
12. Higher prostate-specific antigen levels predict improved survival in patients with hormone-refractory prostate cancer who have skeletal metastases and normal serum alkaline phosphatase.
Xie W; Nakabayashi M; Regan MM; Oh WK
Cancer; 2007 Dec; 110(12):2709-15. PubMed ID: 17960608
[TBL] [Abstract][Full Text] [Related]
13. Pyridinoline cross-linked carboxyterminal telopeptide of type I collagen as a useful marker for monitoring metastatic bone activity in men with prostate cancer.
Noguchi M; Noda S
J Urol; 2001 Sep; 166(3):1106-10. PubMed ID: 11490307
[TBL] [Abstract][Full Text] [Related]
14. Levels of alpha 2 macroglobulin can predict bone metastases in prostate cancer.
Kanoh Y; Ohtani N; Mashiko T; Ohtani S; Nishikawa T; Egawa S; Baba S; Ohtani H
Anticancer Res; 2001; 21(1B):551-6. PubMed ID: 11299802
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of alpha1-antichymotrypsin-PSA complex for predicting bone metastases of prostate cancer.
Kikuchi E; Nakashima J; Ishibashi M; Ohigashi T; Oya M; Nakagawa K; Miyajima A; Murai M
Urology; 2006 Aug; 68(2):371-5. PubMed ID: 16904455
[TBL] [Abstract][Full Text] [Related]
16. [Levels of prostate-specific antigen, acid phosphatase, alkaline phosphatase and pain in the prediction of bone metastases in patients with newly diagnosed prostatic carcinoma].
Kliment J; Eliás B; Svihra J
Rozhl Chir; 1994 Sep; 73(6):300-2. PubMed ID: 7536351
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of bone alkaline phosphatase and prostate specific antigen in the diagnosis of bone metastasis in prostate cancer.
Lorente JA; Morote J; Raventos C; Encabo G; Valenzuela H
J Urol; 1996 Apr; 155(4):1348-51. PubMed ID: 8632571
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of therapeutic effects of strontium-89 on osseous metastases of prostate cancer by bone scanning and B-AKP measurement].
Fan Y; Luo R; Li G; Huang K
Zhonghua Nan Ke Xue; 2004 Mar; 10(3):178-81. PubMed ID: 15080060
[TBL] [Abstract][Full Text] [Related]
19. Simple stratification of survival using bone scan and serum C-reactive protein in prostate cancer patients with metastases.
Nakashima J; Kikuchi E; Miyajima A; Nakagawa K; Oya M; Ohigashi T; Murai M
Urol Int; 2008; 80(2):129-33. PubMed ID: 18362480
[TBL] [Abstract][Full Text] [Related]
20. Capromab Pendetide imaging of prostate cancer.
Haseman MK; Rosenthal SA; Polascik TJ
Cancer Biother Radiopharm; 2000 Apr; 15(2):131-40. PubMed ID: 10803318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
